These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21426063)

  • 1. Targeting inhibitor of apoptosis proteins for therapeutic intervention.
    Ndubaku C; Cohen F; Varfolomeev E; Vucic D
    Future Med Chem; 2009 Nov; 1(8):1509-25. PubMed ID: 21426063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor of apoptosis (IAP) proteins: novel insights into the cancer-relevant targets for cell death induction.
    Fulda S
    ACS Chem Biol; 2009 Jul; 4(7):499-501. PubMed ID: 19588916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists.
    Ndubaku C; Varfolomeev E; Wang L; Zobel K; Lau K; Elliott LO; Maurer B; Fedorova AV; Dynek JN; Koehler M; Hymowitz SG; Tsui V; Deshayes K; Fairbrother WJ; Flygare JA; Vucic D
    ACS Chem Biol; 2009 Jul; 4(7):557-66. PubMed ID: 19492850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
    Varfolomeev E; Blankenship JW; Wayson SM; Fedorova AV; Kayagaki N; Garg P; Zobel K; Dynek JN; Elliott LO; Wallweber HJ; Flygare JA; Fairbrother WJ; Deshayes K; Dixit VM; Vucic D
    Cell; 2007 Nov; 131(4):669-81. PubMed ID: 18022362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor of apoptosis proteins: fascinating biology leads to attractive tumor therapeutic targets.
    Varfolomeev E; Vucic D
    Future Oncol; 2011 May; 7(5):633-48. PubMed ID: 21568679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IAP antagonists: promising candidates for cancer therapy.
    Mannhold R; Fulda S; Carosati E
    Drug Discov Today; 2010 Mar; 15(5-6):210-9. PubMed ID: 20096368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies.
    Fulda S
    Leukemia; 2012 Jun; 26(6):1155-65. PubMed ID: 22230799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathways: targeting inhibitor of apoptosis proteins in cancer--from molecular mechanism to therapeutic application.
    Fulda S
    Clin Cancer Res; 2014 Jan; 20(2):289-95. PubMed ID: 24270683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule pan-IAP antagonists: a patent review.
    Flygare JA; Fairbrother WJ
    Expert Opin Ther Pat; 2010 Feb; 20(2):251-67. PubMed ID: 20100005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancers.
    Fulda S
    Cancer Treat Rev; 2012 Oct; 38(6):760-6. PubMed ID: 22342104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.
    Vince JE; Wong WW; Khan N; Feltham R; Chau D; Ahmed AU; Benetatos CA; Chunduru SK; Condon SM; McKinlay M; Brink R; Leverkus M; Tergaonkar V; Schneider P; Callus BA; Koentgen F; Vaux DL; Silke J
    Cell; 2007 Nov; 131(4):682-93. PubMed ID: 18022363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonists of IAP proteins as cancer therapeutics.
    Dynek JN; Vucic D
    Cancer Lett; 2013 May; 332(2):206-14. PubMed ID: 20685035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting IAP proteins for therapeutic intervention in cancer.
    Fulda S; Vucic D
    Nat Rev Drug Discov; 2012 Feb; 11(2):109-24. PubMed ID: 22293567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor of apoptosis proteins in hematological malignancies.
    Fulda S
    Leukemia; 2009 Mar; 23(3):467-76. PubMed ID: 19039324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer.
    Nachmias B; Ashhab Y; Ben-Yehuda D
    Semin Cancer Biol; 2004 Aug; 14(4):231-43. PubMed ID: 15219616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor of apoptosis proteins as targets for anticancer therapy.
    Fulda S
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathways: targeting death receptors and smac mimetics.
    Fulda S
    Clin Cancer Res; 2014 Aug; 20(15):3915-20. PubMed ID: 24824309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms.
    Reed JC
    Nat Clin Pract Oncol; 2006 Jul; 3(7):388-98. PubMed ID: 16826219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of apoptosis: clinical implications in cancer.
    Mohamed MS; Bishr MK; Almutairi FM; Ali AG
    Apoptosis; 2017 Dec; 22(12):1487-1509. PubMed ID: 29067538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.